A range of GLP-1 weight loss drugs are currently on the market. What are they, what do they do, and where are they available?

Metsera has linked its GLP-1 drug candidate to weight loss of up to 11.3% after 12 weeks, encouraging the biotech to use some ...

I recently learned of Eli Lilly & Co.’s (“Lilly”) recent lawsuit against FDA from Nicole DeFeudis, who interviewed me for her ...

In addition, due to increased demand, many GLP-1 agonists are listed on the FDA's Drug Shortages list. People also must consider their comfort level regarding injections, which is the form of ...

Eli Lilly (LLY) is reportedly seeking to oppose a lawsuit filed by compounding pharmacies over the FDA's determination that ...

As concerns around knockoffs of newer GLP-1 drugs like Ozempic and Wegovy take ... t be allowed to place liraglutide on its compounding list given that FDA-approved generics to Victoza are available.

StudyFinds' Dr. Faith Colemans explains why shopping for weight loss drugs online may save you money but endanger your health ...

Mounjaro and Zepbound, both containing the drug tirzepatide, are exclusive to Eli Lilly but were temporarily added to the FDA's drug shortage list due ... versions of GLP-1 medications, citing ...

While the FDA had considered Lilly's (LLY) tirzepatide and Novo Nordisk's (NVO) semaglutide in short supply for months, Lilly's (LLY) products were taken off the shortage list in October.

The move intensifies an ongoing legal battle, as Novo Nordisk joins its major competitor Eli Lilly in opposing a recent initiative by the Outsourcing Facilities Association to include liraglutide in ...